Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
IntriCon Corporation specializes in the design and manufacturing of micro-miniature and low-power medical devices, primarily serving the hearing health and medical markets. The company operates in the U.S. and internationally, leveraging its proprietary technologies to produce hearing aids and other medical instruments that offer significant customization and efficiency advantages.
IntriCon generates revenue through the sale of hearing aids and medical devices, utilizing a direct-to-consumer model as well as partnerships with healthcare providers. The company benefits from strong pricing power due to its proprietary technologies and established brand reputation, which allows it to maintain a competitive edge in a fragmented market.
Changes in regulatory policies affecting hearing aid sales
Advancements in microelectronics technology that improve product offerings
Consumer demand trends in hearing health
Partnership developments with major healthcare providers
Technological disruption from competitors introducing superior devices
Regulatory changes that could impact product approval processes
Intensifying competition from larger players in the hearing aid market
Emerging startups with innovative technologies that could capture market share
Limited cash flow generation impacting liquidity and operational flexibility
Potential future capital needs for expansion or technology upgrades
moderate - The demand for medical devices is somewhat insulated from economic downturns, but consumer spending on non-essential health products can fluctuate with GDP growth.
Increased interest rates could raise financing costs for IntriCon, potentially impacting its capital expenditures and R&D investments, which are crucial for innovation.
minimal - The company's low debt levels (Debt/Equity of 0.06) reduce its exposure to credit conditions.
growth - Investors looking for companies with high revenue growth potential in the healthcare sector.
moderate - The stock has shown stability, but market conditions can lead to fluctuations.
